***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


Dear All,

When trying to model different oxidised cysteines I encountered varying library descriptions for CSO (single bond; Sg-Od), CSX (double bond; Sg=Od), CSW (2 double bonds; od1=Sg=od2) in the ccp4 monomer library and for libraries generated by PRODRG.

Initially, I just noticed that the ccp4 library description for CSX (where there should be a double-bond between the Sg and the Od) seems to be incomplete. It essentially concerns the double-bond between the sulfur Sg and the Od; whereas PRODRG indicates the corresponding bond length at 1.500 A (which I presume is more realistic), creating library descriptions with the ccp4i sketcher gives 1.800 A for this bond, which I suppose corresponds to a single bond (strangely enough the ccp4 library description for entry CSO, which should have a single bond between the Sg and the Og, contains 1.780 A (i.e. shorter than for the assumed double bond in CSX)). I e-mailed Garib about this and I think this will be taken care of.

However, I then tried to create all oxidised cysteine descriptions from PRODRG (either using the link from the HIC-Up database or by pasting coordinates for an oxidised cysteine). It appears to be me that PRODRG always creates a double-bond between the Sg and the Od when I try to create descriptions for S-hydroxy cysteine (i.e. single bond between Sg-Od). This applies to both the CSO and CEA entries in the HIC-Up database which, as far as I understand, should both describe a single bond between the Sg and Od. I also tried to draw an s-oxycysteine residue using the JME editor, and there, though a single bond is indicated between the Sg and the Od, it has a distance of 1.500 A. Again this would seem to me to be closer to a double bond.

Furthermore, for the CSW (two oxygens with double bond; Od1=Sg=Od2) entry I noticed that with the libraries created from PRODRG when refining in Refmac it seems to move one of the two oxygens out of the density. To illustrate that point: looking down from the Cb towards the Sg (in a particular orientation), significant electron density can be seen towards the left and right of the Sg; i.e. Od1=Sg=Od2), and with the library descriptions created from the CSW entry with the ccp4i sketcher Refmac also refines it well enough. However, with the CSW library descriptions from PRODRG, the refined coordinates looks more like that:

Od1
||
Sg=Od2

The Od1 ends up in a more perpendiular orientation to the Od2 (and compared with the Od1 with the ccp4 libraries) where there is hardly any electron density. I suppose this will have to do with angle restraints and/or chiral volumes but so far have not been digging deeper there.

As I have several of the above mentioned oxidised cysteine species in my current model, I so far I ended up combining libraries from ccp4 (CSO and CSW) and PRODRG (CSX), but this I guess is really just a workaround.

I would be rather curious as to why these differences in the library descriptions exist, and which of the libraries are the more appropriate to use. I was also wondering whether PRODRG creates adequate descriptions for s-oxycysteine. I doesn't seem so to me like that, at first sight.

Finally, I have a question concerning the potential determination of the different species from X-ray data (the oxidation state may be particularly relevant biochemically). My current dataset has minimal Bragg spacing of 2.5 A, and thus does not suffice to unequivocally determine the oxidation state of the cysteines. However, (in addition to biochemical and mass-spectrometry data) I thought I could go about to model the different species (led by difference Fourier maps; and introduce only this change in my model and then calculate maps, density fit, and Rfree for the different modeled oxidised cysteine species). I would eventually model the species that would give me the lowest Rfree. The Rfree differences are rather small (in the range of 0.06) and may thus not be significant. I was thus wondering whether this seems like a reasonable procedure?

I apologize for this lengthy e-mail and thank you already for bearing with me that long.

Any comments would be greatly appreciated!

Many thanks in advance.

Best regards,

Florian
--------------------------------------------
Florian Schmitzberger
Medical Biochemistry and Biophysics
Karolinska Institute
Scheeles vaeg 2
SE-171 77 Stockholm, Sweden
Tel: +46-8-524-86875



Reply via email to